
BI Weekend: Measles Outbreak, US Clean Tech
Bloomberg Intelligence
Health Crisis and Pharmaceutical Developments
This chapter examines the urgent measles outbreaks in the U.S. and the implications for public health regarding vaccination rates. It also discusses a significant merger in the pharmaceutical industry focusing on obesity treatments and the potential threats posed by recent funding cuts to the NIH. The complexities of the healthcare system are further highlighted through a personal narrative, emphasizing the challenges faced by patients navigating insurance and treatment options.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.